 |
인쇄하기
취소
|
Ilang to work with its Chinese arm on Supect
Published: 2013-07-02 06:57:00
Updated: 2013-07-02 06:57:00
Ilyang Pharmaceutical announced last Saturday that it signed a memorandum of understanding with its Chinese arm Yangzhou Ilyang Pharmaceutical in China for the production and sales of Supect (rodotinib).
Yangzhou Ilyang is a joint venture where Ilyang has a 52 percent stake, while Gaoyou City Government owns the remains 48 percent.
The signing ceremony was attended by many high-ranking of...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.